Rothschild Investment LLC Invests $74,000 in Cardinal Health, Inc. (NYSE:CAH)

Rothschild Investment LLC acquired a new stake in shares of Cardinal Health, Inc. (NYSE:CAH) during the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 756 shares of the company’s stock, valued at approximately $74,000.

A number of other large investors have also modified their holdings of CAH. Acadian Asset Management LLC increased its holdings in Cardinal Health by 19.1% in the 1st quarter. Acadian Asset Management LLC now owns 3,723,159 shares of the company’s stock valued at $416,585,000 after buying an additional 598,002 shares during the period. Price T Rowe Associates Inc. MD increased its stake in Cardinal Health by 0.5% in the first quarter. Price T Rowe Associates Inc. MD now owns 2,730,854 shares of the company’s stock valued at $305,584,000 after acquiring an additional 14,030 shares during the period. Norges Bank acquired a new position in Cardinal Health in the fourth quarter worth about $258,499,000. Brandes Investment Partners LP lifted its stake in Cardinal Health by 2.4% during the fourth quarter. Brandes Investment Partners LP now owns 1,221,191 shares of the company’s stock worth $123,096,000 after purchasing an additional 28,042 shares during the period. Finally, Russell Investments Group Ltd. boosted its holdings in Cardinal Health by 25.2% during the first quarter. Russell Investments Group Ltd. now owns 814,894 shares of the company’s stock valued at $91,349,000 after purchasing an additional 163,896 shares in the last quarter. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

CAH has been the subject of several analyst reports. Wells Fargo & Company raised their target price on Cardinal Health from $95.00 to $101.00 and gave the stock an “underweight” rating in a research report on Thursday, August 15th. Robert W. Baird boosted their target price on shares of Cardinal Health from $130.00 to $137.00 and gave the company an “outperform” rating in a research note on Thursday, August 15th. Citigroup dropped their target price on shares of Cardinal Health from $115.00 to $107.00 and set a “neutral” rating for the company in a research report on Friday, July 19th. UBS Group boosted their price target on shares of Cardinal Health from $120.00 to $125.00 and gave the company a “buy” rating in a research report on Thursday, August 15th. Finally, JPMorgan Chase & Co. raised their price objective on shares of Cardinal Health from $111.00 to $123.00 and gave the stock a “neutral” rating in a report on Wednesday, August 21st. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating, seven have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $118.45.

Insider Buying and Selling at Cardinal Health

In other Cardinal Health news, CEO Jason M. Hollar sold 26,716 shares of the company’s stock in a transaction on Friday, August 16th. The shares were sold at an average price of $108.87, for a total transaction of $2,908,570.92. Following the completion of the sale, the chief executive officer now owns 244,091 shares in the company, valued at approximately $26,574,187.17. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other Cardinal Health news, CEO Jason M. Hollar sold 26,716 shares of the firm’s stock in a transaction dated Friday, August 16th. The stock was sold at an average price of $108.87, for a total transaction of $2,908,570.92. Following the transaction, the chief executive officer now owns 244,091 shares in the company, valued at $26,574,187.17. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, insider Jessica L. Mayer sold 16,573 shares of the company’s stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $109.39, for a total value of $1,812,920.47. Following the completion of the sale, the insider now directly owns 75,971 shares of the company’s stock, valued at $8,310,467.69. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 113,963 shares of company stock valued at $12,379,980. 0.15% of the stock is currently owned by insiders.

Cardinal Health Stock Performance

Shares of CAH opened at $113.93 on Thursday. The firm has a market capitalization of $27.75 billion, a price-to-earnings ratio of 50.64, a PEG ratio of 1.54 and a beta of 0.61. Cardinal Health, Inc. has a 52 week low of $85.82 and a 52 week high of $116.05. The business’s fifty day moving average price is $101.78 and its two-hundred day moving average price is $103.80.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings results on Wednesday, August 14th. The company reported $1.84 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.74 by $0.10. Cardinal Health had a negative return on equity of 54.85% and a net margin of 0.37%. The business had revenue of $59.87 billion for the quarter, compared to analysts’ expectations of $58.74 billion. During the same quarter last year, the business earned $1.55 earnings per share. The firm’s quarterly revenue was up 12.1% compared to the same quarter last year. As a group, research analysts forecast that Cardinal Health, Inc. will post 7.61 EPS for the current year.

Cardinal Health Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, October 15th. Investors of record on Tuesday, October 1st will be issued a $0.506 dividend. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.51. This represents a $2.02 annualized dividend and a yield of 1.78%. The ex-dividend date of this dividend is Tuesday, October 1st. Cardinal Health’s dividend payout ratio is currently 89.78%.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.